Title | Incidence of glaucoma after bag-in-the-lens implantation in patients with congenital cataract. |
Abstract Nr. | 1021 |
Purpose | To determine the incidence of glaucoma after congenital cataract surgery using bag-in-the-lens (BIL) implantation technique in paediatric eyes. |
Methods | The study compromised 185 eyes who had congenital cataract surgery with implantation of a BIL between December 1999 and December 2015. Patients with a history of previous intra-ocular surgery, uveitis, anterior segment dysgenesis, congenital glaucoma and traumatic cataract were excluded. Down patients and ectopia lentis patients were initially included. |
Results | 185 eyes of 120 congenital cataract patients (55 unilateral, 65 bilateral) were included. Patient’s age at time of surgery ranged from younger than 1 month to 17,5 years old, with a mean age of 56,5m old. Glaucoma after bag-in-the-lens IOL implantation, with an average follow-up of 52,65 ± 42,2 months, was found in 3 eyes. The glaucoma incidence in our total cohort was 1,62%. 5 glaucoma suspects are currently in close follow-up. As a risk-factor, only the presence of persistent foetal vasculature was statistically significant in our cohort. Although not statistically significant as a risk-factor, our glaucoma cases were all operated before the age of 12 months. |
Conclusion | The glaucoma incidence following bag-in-the-lens IOL implantation is low and thereby comparable to that seen published in recent publications studying the lens-in-the-bag (LIB) paediatric cataract surgery. Wide variation in study design in the literature precludes direct comparison. It might be prudent to emphasize the need for close follow-up of the youngest patients.There is a need for standardization in evaluating glaucoma after cataract surgery. Further prospective studies should be done to review the risk factors. |
Conflict of interest | Yes |
Details of conflicting interests | Dr. M.-J. Tassignon has intellectual property rights to the bag-in-the-lens intraocular lens (U.S. Patent 6 027 531, EU patent 009406794, PCT/120268), which is licensed to Morcher GmbH, Stuttgart, Germany. |
Last name | HELSEN |
Initials | S |
Department | UZA |
City | Edegem |
Last name | Kiekens |
Initials | S |
Department | UZA |
City | Edegem |
Last name | Verkest |
Initials | V |
Department | UZA |
City | Edegem |
Last name | Tassignon |
Initials | MJ |
Department | UZA |
City | Edegem |